FORTZAAR

This brand name is authorized in Germany, Spain, France, Croatia, Netherlands, South Africa

Active ingredients

The drug FORTZAAR contains a combination of these active pharmaceutical ingredients (APIs):

1 Losartan UNII JMS50MPO89 - LOSARTAN

Losartan is a synthetic oral angiotensin-II receptor (type AT1) antagonist. Antihypertensive activity and suppression of plasma aldosterone concentration are maintained, indicating effective angiotensin II receptor blockade. Read about Losartan

2 Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE

Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. Read about Hydrochlorothiazide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FORTZAAR Tablet	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C09DA01	Losartan and diuretics	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics
Discover more medicines within C09DA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01027372, 03652275, 07378368
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 63473
Country: FR	Base de données publique des médicaments	Identifier(s): 60987991, 65214977
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-433648826
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 69302
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/7.1.3/0281